Massimo Volpe
Massimo Volpe
Dipartimento di Medicina clinica e Molecolare, FacoltÓ di Medicina e Psicologia, UniversitÓ Sapienza
Verified email at
Cited by
Cited by
2013 ESH/ESC Guidelines for the management of arterial hypertension
G Mancia, R Fagard, K Narkiewicz, J Redon, A Zanchetti, M B÷hm, ...
Arterial Hypertension 17 (2), 69-168, 2013
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) andá…
B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ...
European heart journal 39 (33), 3021-3104, 2018
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Otherá…
European Journal of Preventive Cardiology 19 (4), 585-667, 2012
Telmisartan, ramipril, or both in patients at high risk for vascular events
Ontarget Investigators
New England Journal of Medicine 358 (15), 1547-1559, 2008
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society ofá…
L RydÚn, E Standl, M Bartnik, G Van den Berghe, J Betteridge, ...
European heart journal 28 (1), 88-136, 2007
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ...
New England Journal of Medicine 367 (23), 2204-2213, 2012
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomisedá…
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ...
The Lancet 372 (9644), 1174-1183, 2008
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era
S De Rosa, C Spaccarotella, C Basso, MP Calabr˛, A Curcio, PP Filardi, ...
European heart journal 41 (22), 2083-2088, 2020
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes
P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ...
New England Journal of Medicine 366 (1), 20-33, 2012
High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species
F Cosentino, M Eto, P De Paolis, B van der Loo, M Bachschmid, V Ullrich, ...
Circulation 107 (7), 1017-1023, 2003
Valsartan for prevention of recurrent atrial fibrillation
GISSI-AF Investigators
New England Journal of Medicine 360 (16), 1606-1617, 2009
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation
F Mahfoud, TF LŘscher, B Andersson, I Baumgartner, R Cifkova, ...
European Heart Journal 34 (28), 2149-2157, 2013
Effects of proprotein convertase subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis
EP Navarese, M Kołodziejczak, V Schulze, PA Gurbel, U Tantry, Y Lin, ...
Annals of internal medicine 163 (1), 40-51, 2015
Acute anti-ischemic effect of testosterone in men with coronary artery disease
GMC Rosano, F Leonardo, P Pagnotta, F Pelliccia, G Panina, ...
Circulation 99 (13), 1666-1670, 1999
Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension
G Iaccarino, G Grassi, C Borghi, C Ferri, M Salvetti, M Volpe
Hypertension 76 (2), 366-372, 2020
Mammalian target of rapamycin signaling in cardiac physiology and disease
S Sciarretta, M Volpe, J Sadoshima
Circulation research 114 (3), 549-564, 2014
Current situation of medication adherence in hypertension
B Vrijens, S Antoniou, M Burnier, A De la Sierra, M Volpe
Frontiers in pharmacology 8, 100, 2017
The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
M Volpe, M Carnovali, V Mastromarino
Clinical Science 130 (2), 57-77, 2016
Insulin-like growth factor-1 as a vascular protective factor
E Conti, C Carrozza, E Capoluongo, M Volpe, F Crea, C Zuppi, ...
Circulation 110 (15), 2260-2265, 2004
Natriuretic peptides in cardiovascular diseases: current use and perspectives
M Volpe, S Rubattu, J Burnett Jr
European heart journal 35 (7), 419-425, 2014
The system can't perform the operation now. Try again later.
Articles 1–20